1. Taylor EC. New pathways from pteridines. Design and synthesis of a new class of potent and selective antitumor agents. J Heterocyclic Chem 1990;27:1–12.
2. Beardsley GP, Taylor EC, Grindey GB, Moran RG. Deaza derivatives of tetrahydrofolic acid. A new class of folate antimetabolite. In: Cooper BA, Whitehead VM, eds. Chemistry and Biology of Pteridines. DeGruyter, Berlin, 1986, pp. 953–957.
3. Shih C, Grindey GB, Houghton PJ, Houghton JA. In vivo antitumor activity of 5,10-dideazatetrahydrofolic acid (DDATHF) and its diastereomeric isomers. Proc Am Assoc Cancer Res 1991; 32:324.
4. Muggia F, Martin T, Ray M, Leichman CG, Grunberg S, Gill I, Moran R, Dyke R, Grindey G. Phase I clinical trial of weekly 5,10-dideazatetrahydrofolate (LY 26418, DDATHF-B). Proc Amer Assoc Clin Oncol 1990; 9:74.
5. Grindey GB, Alati T, Shih C. Reversal of the toxicity but not the antitumor activity of lometrexol by folic acid. Proc Am Assoc Cancer Res 1991; 32:324.